Abbvie Biotech Ventures

Profile

Abbvie Biotech Ventures is a venture capital group based in the United States, founded as part of AbbVie, a prominent pharmaceutical company. The team leverages its extensive industry experience to identify and support promising healthcare innovations across various sub-sectors. The firm prides itself on its commitment to funding potential breakthroughs in biotechnology and advancing new treatments that address significant medical needs. This focus distinguishes them as an investor closely integrated with a global leader in the pharmaceutical sector.

Abbvie Biotech Ventures invests primarily in healthcare sectors, with a focus on immunology, oncology, neuroscience, eye care, and other specialties. They target companies developing novel and innovative therapeutic solutions. Although specific check sizes are not disclosed, their affiliation suggests an ability to engage in substantial funding rounds. Their investments are global, aligning with AbbVie's worldwide operations, but the exact geographic focus for venture investments isn't detailed on their site.

Select investments by this VC arm of Abbvie include early-stage biotech firms working on groundbreaking treatments in areas such as AI and data convergence, precision medicine, and patient-focused drug development, though specific portfolio companies are not explicitly mentioned on their website.